T Cell Assays and MIATA: The Essential Minimum for Maximum Impact von Britten, C.M., Janetzki, S., Butterfield, L.H., Ferrari, G., Gouttefangeas, C., Huber, C., Kalos, M., Levitsky, H.I., Maecker, H.T., Melief, C.J.M., O’Donnell-Tormey, J., Odunsi, K., Old, L.J., Ottenhoff, T.H.M., Ottensmeier, C., Pawelec, G., Roederer, M., Roep, B.O., Romero, P., van der Burg, S.H., Walter, S., Hoos, A., Davis, M.M.

Volltext

Improving the efficacy of cancer immunotherapy von Copier, J, Dalgleish, A.G, Britten, C.M, Finke, L.H, Gaudernack, G, Gnjatic, S, Kallen, K, Kiessling, R, Schuessler-Lenz, M, Singh, H, Talmadge, J, Zwierzina, H, Håkansson, L

Volltext

Minimal information about T cell assays: the process of reaching the community of T cell immunologists in cancer and beyond von Britten, C. M., Janetzki, S., van der Burg, S. H., Huber, C., Kalos, M., Levitsky, H. I., Maecker, H. T., Melief, C. J. M., O’Donnell-Tormey, J., Odunsi, K., Old, L. J., Pawelec, G., Roep, B. O., Romero, P., Hoos, A., Davis, M. M.

Volltext

Toward the harmonization of immune monitoring in clinical trials: Quo vadis? von Britten, C. M., Janetzki, S., van der Burg, S. H., Gouttefangeas, C., Hoos, A.

Volltext

Serum is not required for ex vivo IFN-γ ELISPOT: a collaborative study of different protocols from the European CIMT Immunoguiding Program von Mander, A, Gouttefangeas, C, Ottensmeier, C, Welters, M. J. P, Low, L, van der Burg, S. H, Britten, C. M

Volltext

Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI) von Janetzki, Sylvia, Panageas, Katherine S., Ben-Porat, Leah, Boyer, Jean, Britten, Cedrik M., Clay, Timothy M., Kalos, Michael, Maecker, Holden T., Romero, Pedro, Yuan, Jianda, Martin Kast, W., Hoos, Axel

Volltext

Performance of serum-supplemented and serum-free media in IFNγ Elispot Assays for human T cells von Janetzki, Sylvia, Price, L, Britten, C. M, van der Burg, S. H, Caterini, J, Currier, J. R, Ferrari, G, Gouttefangeas, C, Hayes, P, Kaempgen, E, Lennerz, V, Nihlmark, K, Souza, V, Hoos, A

Volltext

Cancer immunotherapy 2005: Mainz, Germany, 12-13 May 2005 von Britten, C M, Gouttefangeas, C, Kreiter, S

Volltext

Cancer classification using the Immunoscore: a worldwide task force von Galon, Jérôme, Pagès, Franck, Marincola, Francesco M, Angell, Helen K, Thurin, Magdalena, Lugli, Alessandro, Zlobec, Inti, Berger, Anne, Bifulco, Carlo, Botti, Gerardo, Tatangelo, Fabiana, Britten, Cedrik M, Kreiter, Sebastian, Chouchane, Lotfi, Delrio, Paolo, Arndt, Hartmann, Asslaber, Martin, Maio, Michele, Masucci, Giuseppe V, Mihm, Martin, Vidal-Vanaclocha, Fernando, Allison, James P, Gnjatic, Sacha, Hakansson, Leif, Huber, Christoph, Singh-Jasuja, Harpreet, Ottensmeier, Christian, Zwierzina, Heinz, Laghi, Luigi, Grizzi, Fabio, Ohashi, Pamela S, Shaw, Patricia A, Clarke, Blaise A, Wouters, Bradly G, Kawakami, Yutaka, Hazama, Shoichi, Okuno, Kiyotaka, Wang, Ena, O'Donnell-Tormey, Jill, Lagorce, Christine, Pawelec, Graham, Nishimura, Michael I, Hawkins, Robert, Lapointe, Réjean, Lundqvist, Andreas, Khleif, Samir N, Ogino, Shuji, Gibbs, Peter, Waring, Paul, Sato, Noriyuki, Torigoe, Toshihiko, Itoh, Kyogo, Patel, Prabhu S, Shukla, Shilin N, Palmqvist, Richard, Nagtegaal, Iris D, Wang, Yili, D'Arrigo, Corrado, Kopetz, Scott, Sinicrope, Frank A, Trinchieri, Giorgio, Gajewski, Thomas F, Ascierto, Paolo A, Fox, Bernard A

Volltext

Cancer Immunotherapy 2004: Mainz, Germany, 6-7 may 2004 von Britten, C M, Mueller, L, Knights, A, Pawelec, G

Volltext

Talking with children about death and dying von Pettle, S A, Britten, C M

Volltext

Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers von BUTTERFIELD, Lisa H, KAROLINA PALUCKA, A, MAECKER, Holden T, MAINO, Vernon C, MAIO, Michele, MALYGUINE, Anatoli, MASUCCI, Giuseppe, PAWELEC, Graham, POTTER, Douglas M, RIVOLTINI, Licia, SALAZAR, Lupe G, SCHENDEL, Dolores J, BRITTEN, Cedrik M, SLINGLUFF, Craig L, WENRU SONG, STRONCEK, David F, TAHARA, Hideaki, THURIN, Magdalena, TRINCHIERI, Giorgio, VAN DER BURG, Sjoerd H, WHITESIDE, Theresa L, WIGGINTON, Jon M, MARINCOLA, Francesco, DHODAPKAR, Madhav V, KHLEIF, Samir, FOX, Bernard A, DISIS, Mary L, HAKANSSON, Leif, JANETZKI, Sylvia, KAWAKAMI, Yutaka, KLEEN, Thomas-Oliver, LEE, Peter P, MACCALLI, Cristina

Volltext

Maturation of Dendritic Cells Is a Prerequisite for Inducing Immune Responses in Advanced Melanoma Patients von DE VRIES, I. Jolanda M, LESTERHUIS, W. Joost, FIGDOR, Carl G, PUNT, Cornelis J. A, SCHARENBORG, Nicole M, ENGELEN, Linda P. H, RUITER, Dirk J, GERRITSEN, Marie-Jeanne P, CROOCKEWIT, Sandra, BRITTEN, Cedrik M, TORENSMA, Ruurd, ADEMA, Gosse J

Volltext

Defining the critical hurdles in cancer immunotherapy von Fox, Bernard A, Schendel, Dolores J, Butterfield, Lisa H, Aamdal, Steinar, Allison, James P, Ascierto, Paolo Antonio, Atkins, Michael B, Bartunkova, Jirina, Bergmann, Lothar, Berinstein, Neil, Bonorino, Cristina C, Borden, Ernest, Bramson, Jonathan L, Britten, Cedrik M, Cao, Xuetao, Carson, William E, Chang, Alfred E, Characiejus, Dainius, Choudhury, A Raja, Coukos, George, de Gruijl, Tanja, Dillman, Robert O, Dolstra, Harry, Dranoff, Glenn, Durrant, Lindy G, Finke, James H, Galon, Jerome, Gollob, Jared A, Gouttefangeas, Cécile, Grizzi, Fabio, Guida, Michele, Håkansson, Leif, Hege, Kristen, Herberman, Ronald B, Hodi, F Stephen, Hoos, Axel, Huber, Christoph, Hwu, Patrick, Imai, Kohzoh, Jaffee, Elizabeth M, Janetzki, Sylvia, June, Carl H, Kalinski, Pawel, Kaufman, Howard L, Kawakami, Koji, Kawakami, Yutaka, Keilholtz, Ulrich, Khleif, Samir N, Kiessling, Rolf, Kotlan, Beatrix, Kroemer, Guido, Lapointe, Rejean, Levitsky, Hyam I, Lotze, Michael T, Maccalli, Cristina, Maio, Michele, Marschner, Jens-Peter, Mastrangelo, Michael J, Masucci, Giuseppe, Melero, Ignacio, Melief, Cornelius, Murphy, William J, Nelson, Brad, Nicolini, Andrea, Nishimura, Michael I, Odunsi, Kunle, Ohashi, Pamela S, O'Donnell-Tormey, Jill, Old, Lloyd J, Ottensmeier, Christian, Papamichail, Michael, Parmiani, Giorgio, Pawelec, Graham, Proietti, Enrico, Qin, Shukui, Rees, Robert, Ribas, Antoni, Ridolfi, Ruggero, Ritter, Gerd, Rivoltini, Licia, Romero, Pedro J, Salem, Mohamed L, Scheper, Rik J, Seliger, Barbara, Sharma, Padmanee, Shiku, Hiroshi, Singh-Jasuja, Harpreet, Song, Wenru, Straten, Per Thor, Tahara, Hideaki, Tian, Zhigang, van Der Burg, Sjoerd H, von Hoegen, Paul, Wang, Ena, Welters, Marij Jp, Winter, Hauke, Withington, Tara, Wolchok, Jedd D, Xiao, Weihua, Zitvogel, Laurence

Volltext

Impfstrategien zur Prävention oder Therapie von Tumoren von Britten, C. M, Sahin, U

Volltext

Serum is not required for ex vivo IFN-g ELISPOT: a collaborative study of different protocols from the European CIMT Immunoguiding Program von Mander, A, Gouttefangeas, C, Ottensmeier, C, Welters, MJP, Low, L, Burg, SH, Britten, C M

Volltext

The use of HLA-A0201-transfected K562 as standard antigen-presenting cells for CD8 + T lymphocytes in IFN-γ ELISPOT assays von Britten, Cedrik M, Meyer, Ralf G, Kreer, Tanja, Drexler, Ingo, Wölfel, Thomas, Herr, Wolfgang

Volltext

CIMT meets strategies for immune therapy. Report and abstracts of the 4th International Meeting of the Association for Immunotherapy of Cancer, Mainz, Germany, 4-5 May 2006 von Gouttefangeas, C, Britten, C M, Badalians, E Derhovanessian, Pawelec, G

Volltext

Performance of serum-supplemented and serum-free media in IFNg Elispot Assays for human T cells von Janetzki, Sylvia, Price, L, Britten, C M, Burg, SH, Caterini, J, Currier, J R, Ferrari, G, Gouttefangeas, C, Hayes, P, Kaempgen, E, Lennerz, V, Nihlmark, K, Souza, V, Hoos, A

Volltext

Performance of serum-supplemented and serum-free media in IFN[gamma] Elispot Assays for human T cells von Janetzki, Sylvia, Price, L, Britten, C M, van der Burg, S H, Caterini, J, Currier, J R, Ferrari, G, Gouttefangeas, C, Hayes, P, Kaempgen, E, Lennerz, V, Nihlmark, K, Souza, V, Hoos, A

Volltext